Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)

Autor: Bahig, Houda, Tonneau, Marion, Blais, Normand, Wong, Philip, Filion, Edith, Campeau, Marie-Pierre, Vu, Toni, Al-Saleh, Afnan, Tehfé, Mustapha, Florescu, Marie, Roberge, David, Masucci, Laura, Richard, Corentin, Menard, Cynthia, Routy, Bertrand
Zdroj: In Clinical and Translational Radiation Oncology March 2022 33:115-119
Databáze: ScienceDirect